These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


429 related items for PubMed ID: 6789494

  • 1. Inhibition of human platelet functions by verapamil.
    Ikeda Y, Kikuchi M, Toyama K, Watanabe K, Ando Y.
    Thromb Haemost; 1981 Apr 30; 45(2):158-61. PubMed ID: 6789494
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG, Littleton JM.
    Thromb Haemost; 1982 Aug 24; 48(1):49-53. PubMed ID: 6813995
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide.
    Han P, Boatwright C, Ardlie NG.
    Thromb Haemost; 1982 Apr 30; 47(2):150-3. PubMed ID: 7101234
    [Abstract] [Full Text] [Related]

  • 4. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
    Han P, Boatwright C, Ardlie NG.
    Thromb Haemost; 1983 Aug 30; 50(2):513-7. PubMed ID: 6314581
    [Abstract] [Full Text] [Related]

  • 5. Verapamil and collagen-induced platelet reactions--evidence for a role for intracellular calcium in platelet activation.
    Han P, Boatwright C, Ardlie NG.
    Thromb Haemost; 1983 Aug 30; 50(2):537-40. PubMed ID: 6415847
    [Abstract] [Full Text] [Related]

  • 6. Thrombin-induced platelet secretion. Further evidence for a specific pathway.
    Shuman MA, Botney M, Fenton JW.
    J Clin Invest; 1979 Jun 30; 63(6):1211-8. PubMed ID: 376555
    [Abstract] [Full Text] [Related]

  • 7. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL, Perry DW, Rand ML, Packham MA.
    Thromb Haemost; 1997 Apr 30; 77(4):741-7. PubMed ID: 9134653
    [Abstract] [Full Text] [Related]

  • 8. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S, Westwick J, Kakkar VV.
    Biochem Pharmacol; 1984 Oct 01; 33(19):3025-35. PubMed ID: 6091666
    [Abstract] [Full Text] [Related]

  • 9. Effects of tris on responses of human and rabbit platelets to aggregating agents.
    Packham MA, Guccione MA, Nina M, Kinlough-Rathbone RL, Mustard JF.
    Thromb Haemost; 1984 Apr 30; 51(2):140-4. PubMed ID: 6429880
    [Abstract] [Full Text] [Related]

  • 10. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
    Salvemini D, de Nucci G, Vane JR.
    Thromb Haemost; 1991 Apr 08; 65(4):421-4. PubMed ID: 1647553
    [Abstract] [Full Text] [Related]

  • 11. Effects of verapamil on platelet aggregation and serum thromboxane synthesis in vitro and in vivo.
    Strano A, Davì G, Novo S, Custro N, Mattina A, Gallo V.
    Int Angiol; 1985 Apr 08; 4(3):379-82. PubMed ID: 3913716
    [Abstract] [Full Text] [Related]

  • 12. An analysis of the mechanism of local anesthetic inhibition of platelet aggregation and secretion.
    Feinstein MG, Fiekers J, Fraser C.
    J Pharmacol Exp Ther; 1976 Apr 08; 197(1):215-28. PubMed ID: 772186
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of verapamil on platelet aggregation.
    Glusa E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Apr 08; 115(4):469-73. PubMed ID: 2465955
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of Ca2+-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil, on platelet aggregation in vitro.
    Ono H, Kimura M.
    Arzneimittelforschung; 1981 Apr 08; 31(7):1131-4. PubMed ID: 7196762
    [Abstract] [Full Text] [Related]

  • 17. Properties of washed human platelets.
    Kinlough-Rathbone RL, Mustard JF, Packham MA, Perry DW, Reimers HJ, Cazenave JP.
    Thromb Haemost; 1977 Apr 30; 37(2):291-308. PubMed ID: 327607
    [Abstract] [Full Text] [Related]

  • 18. [Potentiating effect of some fatty acids on platelet aggregation induced with ADP, collagen and 1-epinephrine].
    Musso R, Russo M, Raimondo V.
    Boll Soc Ital Biol Sper; 1980 Mar 30; 56(6):569-75. PubMed ID: 7378191
    [Abstract] [Full Text] [Related]

  • 19. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
    Rendu F, Bachelot C, Molle D, Caen J, Guez D.
    J Cardiovasc Pharmacol; 1993 Mar 30; 22 Suppl 6():S57-63. PubMed ID: 7508063
    [Abstract] [Full Text] [Related]

  • 20. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL, El Mouelhi M, Pfannkuche HJ, Rose K, Marro M, Angiolillo DJ.
    Am J Ther; 2010 Mar 30; 17(6):543-52. PubMed ID: 19797939
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.